New cancer drug trial halted early after testing in 29 patients
Disease control
Terminated
This early-stage trial tested a new drug called DT-9081 in 29 adults with advanced solid tumours that had stopped responding to standard treatments. The main goal was to find a safe dose and check for side effects. The study was stopped early, so results are limited.
Phase: PHASE1 • Sponsor: Domain Therapeutics SA • Aim: Disease control
Last updated May 26, 2026 15:15 UTC